JORGE J CORONA
Allopathic & Osteopathic Physicians|Ophthalmology|Ophthalmic Plastic and Reconstructive Surgery DALLAS, TX NPI 1104816404
Browse related groups: Allopathic & Osteopathic Physicians|Ophthalmology|Ophthalmic Plastic and Reconstructive Surgery TX Amgen Inc. All categories
General Payments — all program years on this page
$2,468.68
- Category: General Payments
- Program years: PY2018–2024
- Record count: 67
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $232.75 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $232.75 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $105.19 | 5 |
| Alcon Laboratories Inc | $51.93 | 1 |
| AXOGEN | $39.82 | 1 |
| Merz Pharmaceuticals, LLC | $35.81 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1110608458 | Alcon Vision LLC | $51.93 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111554439 | Amgen Inc. | $24.04 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111554441 | Amgen Inc. | $20.13 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111554443 | Amgen Inc. | $18.07 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111554445 | Amgen Inc. | $19.72 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111554447 | Amgen Inc. | $23.23 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137950696 | Merz Pharmaceuticals, LLC | $35.81 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143644030 | AXOGEN | $39.82 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.